PLEASANTON, Calif., July 22 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the second quarter and first six months of fiscal 2010 on Thursday, July 29. The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, July 29, hosted by Gary F.
HeartWare Announces Board Succession
FRAMINGHAM, Mass. and SYDNEY, June 24 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that C.
From USA to India, a Patient Gets Back the Rhythm of his Heart
BANGALORE, India, June 23, 2010 /PRNewswire/ -- John L Parker, a
64-year-old American, sports enthusiast, marathon runner and writer, traveled
to Bangalore to undergo a complicated heart rhythm disorder treatment.
Thoratec Presentation at Wells Fargo Conference to Be Webcast
PLEASANTON, Calif., June 18 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it will be participating in the Wells Fargo Securities Healthcare Conference on Thursday, June 24.
Gary F.
